New Op-Ed in STAT News: Address liquid biopsy disparities today to ensure equity in outcomes tomorrow
Medical innovations risk benefiting only a small group of people, potentially widening existing health disparities if not addressed early on.
Liquid biopsy applications in cancer care are rapidly evolving, with the healthcare community embracing their minimally invasive nature and ease of collection. These qualities make liquid biopsy a promising tool in the fight against existing cancer disparities.
In this STAT News piece, our members Gebra Cuyun Carter and Caitlin Kubler build on a recent publication by our Accessibility Working Group, tackling the challenges and roadmap for the equitable implementation of liquid biopsy. They emphasize the need to overcome existing barriers to adoption by diversifying clinical trials, ensuring fair coverage by payers, and providing comprehensive education for both patients and providers.
Read the full article here.
